Belzutifan for Advanced Pheochromocytoma or Paraganglioma

Belzutifan showed antitumor activity with durable responses in participants with advanced pheochromocytoma or paraganglioma. (Funded by Merck Sharp and Dohme, a subsidiary of Merck [Rahway, NJ]; LITESPARK-015 ClinicalTrials.gov number, NCT04924075.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2025-10-18
DOI
https://doi.org/10.1056/nejmoa2504964
Citations
12
Primary Topic
Adrenal and Paraganglionic Tumors
Type
article
Field-Weighted Citation Impact
24.08
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Belzutifan for Advanced Pheochromocytoma or Paraganglioma

Alfredo Berruti, Tobias Else, Girish S. Naik, Rohini Sharma et al.
12 citations
New England Journal of Medicine
Adrenal and Paraganglionic Tumors
24.08
article

Belzutifan for Advanced Pheochromocytoma or Paraganglioma

Alfredo Berruti, Tobias Else, Girish S. Naik, Rohini Sharma, Sophie Moog, Knut Mai, Andreas Hallqvist, Martin Faßnacht, Edward M. Wolin, Alexander Gozman, Jaydira Del Rivero, Elena Artamonova, Camilo Jiménez, Othon Iliopoulos, Olivier Huillard, Rocio García‐Carbonero, Alice Durand, Raymond Woo-Jun Jang, Francesca Spada, Amos Odeleye-Ajakaye, Mikkel Andreassen, Jaume Capdevila, Staffan Welin, Joseph D. Ruether, Andrew Hendifar
article en
12 citations

Abstract

Belzutifan showed antitumor activity with durable responses in participants with advanced pheochromocytoma or paraganglioma. (Funded by Merck Sharp and Dohme, a subsidiary of Merck [Rahway, NJ]; LITESPARK-015 ClinicalTrials.gov number, NCT04924075.).

New England Journal of MedicineVol. 393(20)
Hebron University (PS), Cedars-Sinai Medical Center (US), Merck & Co., Inc., Rahway, NJ, USA (United States) (US), National Institutes of Health (US), Uppsala University Hospital (SE), The University of Texas MD Anderson Cancer Center (US), University of Calgary (CA), University of Michigan (US), Sahlgrenska University Hospital (SE), Institut Gustave Roussy (FR), Princess Margaret Cancer Centre (CA), Rigshospitalet (DK), Humboldt-Universität zu Berlin (DE), European Neuroendocrine Tumor Society (DE), Massachusetts General Hospital (US), Hôpital Cochin (FR), Ministry of Health (ES), Comprehensive Cancer Center Mainfranken (DE), Hospital Universitario 12 De Octubre (ES), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Hôpitaux Universitaires Paris-Ouest (FR), Hôpital Edouard Herriot (FR), Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale (FR), Vall d'Hebron Hospital Universitari (ES), National Cancer Institute (US), German Institute of Human Nutrition (DE), Imperial College London (GB), European Institute of Oncology (IT), University of Brescia (IT), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 0%
Adrenal and Paraganglionic Tumors
24.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.